Physician profile
John W Tillett
NPI 1003090382
$20,911.41
in general payments reported to CMS, 2019-2025
29 companies · $14K in 2025
The $14K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $795 · 2020: $142 · 2021: $1,481 · 2022: $811 · 2023: $487 · 2024: $2,945 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,873 · Travel and Lodging: $2,963 · Food and Beverage: $2,709 · Honoraria: $2,275 · Debt Forgiveness: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,872.50 |
| Travel and Lodging | $2,963.00 |
| Food and Beverage | $2,708.56 |
| Honoraria | $2,275.00 |
| Debt Forgiveness | $862.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $4,159.89 | 2021-2025 | Jelmyto |
| Ferring Pharmaceuticals INC. | $3,793.13 | 2024-2025 | Adstiladrin |
| Boston Scientific Corporation | $3,271.11 | 2022-2025 | Ams 700, Rezum Generator, Ams 700 Cxr Rte Kit |
| Pfizer INC. | $2,605.16 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $1,301.55 | 2019-2025 | |
| Telix Pharmaceuticals | $1,207.76 | 2022-2024 | Illuccix |
| Olympus America INC. | $862.65 | 2025 | |
| Coloplast Corp | $663.48 | 2025 | |
| Astellas Pharma US INC | $603.66 | 2019-2022 | |
| Gyrus Acmi, INC. | $600.00 | 2025 | Uretero-Reno Videoscope |
| Abbvie INC. | $418.36 | 2019-2023 | Botox, Lupron Depot |
| Janssen Biotech, INC. | $297.23 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Dendreon Pharmaceuticals LLC | $262.59 | 2023-2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $137.02 | 2019-2023 | |
| Laborie Medical Technologies Corp. | $117.28 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $103.39 | 2019-2023 | Xiaflex |
| Intuitive Surgical, INC. | $98.42 | 2022 | |
| Allergan, INC. | $87.54 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $71.37 | 2025 | Lynparza |
| Blue Earth Diagnostics | $52.26 | 2019 | |
| Neotract INC. | $48.53 | 2019 | |
| Sumitomo Pharma America, INC. | $29.32 | 2024 | Orgovyx |
| Rochester Medical Corporation | $22.43 | 2022 | |
| Avadel Specialty Pharmaceuticals, LLC | $19.84 | 2019 | |
| Tolmar, INC. | $18.01 | 2024 | |
| Amgen INC. | $17.45 | 2019 | |
| Aytu Biopharma, INC. | $17.29 | 2019 | |
| Novo Nordisk INC | $13.42 | 2024 | |
| Rgh Enterprises LLC | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tillett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.